|
PJA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.92269999710737E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.45310000382915E-08 |
| Normal-vs-Stage2 |
4.203700E-02 |
| Normal-vs-Stage3 |
7.10159997474591E-09 |
| Normal-vs-Stage4 |
1.68870473160609E-11 |
| Stage1-vs-Stage2 |
2.064000E-02 |
| Stage1-vs-Stage3 |
3.048800E-01 |
| Stage1-vs-Stage4 |
1.584610E-03 |
| Stage2-vs-Stage3 |
1.089950E-02 |
| Stage2-vs-Stage4 |
1.818030E-04 |
| Stage3-vs-Stage4 |
6.794100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.35909999815698E-08 |
| Normal-vs-AfricanAmerican |
2.28349999999988E-05 |
| Normal-vs-Asian |
1.64280000003458E-06 |
| Caucasian-vs-AfricanAmerican |
5.379800E-01 |
| Caucasian-vs-Asian |
7.228600E-01 |
| AfricanAmerican-vs-Asian |
7.258600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2235999991006E-08 |
| Normal-vs-Female |
3.98439999882427E-08 |
| Male-vs-Female |
1.341960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.20520000540725E-08 |
| Normal-vs-Age(41-60Yrs) |
7.66869999946351E-07 |
| Normal-vs-Age(61-80Yrs) |
2.2942999999831E-07 |
| Normal-vs-Age(81-100Yrs) |
2.897300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.344400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.977200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.486800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.162400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.352200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.924000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.85009999998221E-07 |
| Classical-VS-Follicular |
2.599200E-01 |
| Classical-VS-Other |
3.551800E-01 |
| Classical-VS-Normal |
7.97390000029097E-07 |
| Tall-VS-Follicular |
1.859700E-03 |
| Tall-VS-Other |
5.977000E-01 |
| Tall-VS-Normal |
3.64375196681976E-13 |
| Follicular-VS-Other |
5.782000E-01 |
| Follicular-VS-Normal |
2.72530000011706E-07 |
| Other-VS-Normal |
4.381200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.03029999999993E-05 |
| Normal-vs-N1 |
6.99440505513849E-15 |
| N0-vs-N1 |
8.29159999549134E-08 |
|
|
